Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer's Disease

被引:7
|
作者
Zhu, Yueli [1 ]
Guo, Xiaoming [2 ]
Zhu, Feng [1 ]
Zhang, Qin [1 ,3 ]
Yang, Yunmei [1 ,3 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Geriatr, Hangzhou 310003, Peoples R China
[2] Tongde Hosp Zhejiang Prov, Dept Neurosurg, Hangzhou 310012, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Key Lab Diag & Treatment Aging & Phys Chem Injury, Hangzhou 310003, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; growth-associated protein 43; Apolipoprotein E epsilon 4; synaptic loss; biomarker; AMYLOID-BETA; SYNAPSE LOSS; PROTEIN; TAU; NEUROGRANIN; GENOTYPE; CA1;
D O I
10.3390/cells12010013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The growth-associated protein 43 (GAP-43) is a presynaptic phosphoprotein in cerebrospinal fluid (CSF). The epsilon 4 allele of apolipoprotein E (APOE) is an important genetic risk factor for Alzheimer's disease (AD). We aimed to evaluate the association of CSF GAP-43 with cognition and whether this correlation was related to the APOE epsilon 4 status. We recruited participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, and they were divided into cognitively normal (CN) epsilon 4 negative (CN epsilon 4-), CN epsilon 4 positive (CN epsilon 4+), mild cognitive impairment (MCI) epsilon 4 negative (MCI epsilon 4-), MCI epsilon 4 positive (MCI epsilon 4+), AD epsilon 4 negative (AD epsilon 4-), and AD epsilon 4 positive (AD epsilon 4+) groups. Spearman's correlation was utilized to evaluate the relationship between CSF GAP-43 and core AD biomarkers at the baseline. We performed receiver-operating characteristic (ROC) curve analyses to investigate the diagnostic accuracy of CSF GAP-43. The correlations between CSF GAP-43 and the Mini-Mental State Examination (MMSE) scores and brain atrophy at baseline were assessed by using multiple linear regression, while the association between CSF GAP-43 and MMSE scores at the follow-up was tested by performing the generalized estimating equation (GEE). The role of CSF GAP-43 in the conversion from MCI to AD was evaluated using the Cox proportional hazard model. We found that the CSF GAP-43 level was significantly increased in MCI epsilon 4+, AD epsilon 4- and AD epsilon 4+ groups compared with CN epsilon 4- or MCI epsilon 4- group. The negative associations between the CSF GAP-43 and MMSE scores at the baseline and follow-up were found in MCI epsilon 4- and MCI epsilon 4+ groups. In addition, baseline CSF GAP-43 was able to predict the clinical progression from MCI to AD. CSF GAP-43 may be a promising biomarker to screen cognition for AD. The effects of CSF GAP-43 on cognition were suspected to be relevant to APOE epsilon 4 status.
引用
收藏
页数:13
相关论文
共 50 条
  • [11] Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer's disease
    Franzmeier, Nicolai
    Dehsarvi, Amir
    Steward, Anna
    Biel, Davina
    Dewenter, Anna
    Roemer, Sebastian Niclas
    Wagner, Fabian
    Gross, Mattes
    Brendel, Matthias
    Moscoso, Alexis
    Arunachalam, Prithvi
    Blennow, Kaj
    Zetterberg, Henrik
    Ewers, Michael
    Schoell, Michael
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [12] Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease
    Nicolai Franzmeier
    Amir Dehsarvi
    Anna Steward
    Davina Biel
    Anna Dewenter
    Sebastian Niclas Roemer
    Fabian Wagner
    Mattes Groß
    Matthias Brendel
    Alexis Moscoso
    Prithvi Arunachalam
    Kaj Blennow
    Henrik Zetterberg
    Michael Ewers
    Michael Schöll
    Nature Communications, 15
  • [13] Prevalence of mild behavioural impairment and its association with cognitive and functional impairment in normal cognition, mild cognitive impairment, and mild Alzheimer's dementia
    Park, Jong-Il
    PSYCHOGERIATRICS, 2024, 24 (03) : 555 - 564
  • [14] CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer’s disease
    Qiang Qiang
    Loren Skudder-Hill
    Tomoko Toyota
    Wenshi Wei
    Hiroaki Adachi
    Scientific Reports, 12
  • [15] Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
    Sandelius, Asa
    Portelius, Erik
    Kallen, Asa
    Zetterberg, Henrik
    Rot, Uros
    Olsson, Bob
    Toledo, Jon B.
    Shaw, Leslie M.
    Lee, Virginia M. Y.
    Irwin, David J.
    Grossman, Murray
    Weintraub, Daniel
    Chen-Plotkin, Alice
    Wolk, David A.
    McCluskey, Leo
    Elman, Lauren
    Kostanjevecki, Vesna
    Vandijck, Manu
    McBride, Jennifer
    Trojanowski, John Q.
    Blennow, Kaj
    ALZHEIMERS & DEMENTIA, 2019, 15 (01) : 55 - 64
  • [16] CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer's disease
    Qiang, Qiang
    Skudder-Hill, Loren
    Toyota, Tomoko
    Wei, Wenshi
    Adachi, Hiroaki
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [17] APOE Genotypes and Brain Imaging Classes in Normal Cognition, Mild Cognitive Impairment, and Alzheimer's Disease: A Longitudinal Study
    Camarda, Cecilia
    Torelli, Paola
    Pipia, Carmela
    Sottile, Gianluca
    Cilluffo, Giovanna
    Camarda, Rosolino
    CURRENT ALZHEIMER RESEARCH, 2020, 17 (08) : 766 - 780
  • [18] ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease
    Apostolova, Liana G.
    Hwang, Kristy S.
    Kohannim, Omid
    Avila, David
    Elashoff, David
    Jack, Clifford R., Jr.
    Shaw, Leslie
    Trojanowski, John Q.
    Weiner, Michael W.
    Thompson, Paul M.
    NEUROIMAGE-CLINICAL, 2014, 4 : 461 - 472
  • [19] Association between handgrip strength and cognition in a Chinese population with Alzheimer's disease and mild cognitive impairment
    Su, Hang
    Sun, Xiaokang
    Li, Fang
    Guo, Qihao
    BMC GERIATRICS, 2021, 21 (01)
  • [20] Association between handgrip strength and cognition in a Chinese population with Alzheimer’s disease and mild cognitive impairment
    Hang Su
    Xiaokang Sun
    Fang Li
    Qihao Guo
    BMC Geriatrics, 21